Bladder cancer is more aggressive and more advanced in South
Moscow announces advanced trials for new COVID-19 vaccine
The mayor of Moscow invited residents Wednesday to join trials
Clinical trial reveals new subtypes of advanced pancreatic cancer
Researchers at the Ontario Institute for Cancer Research (OICR) and
Advanced MRI brain scan may help predict stroke-related dementia
An advanced Magnetic Resonance Imaging (MRI) brain scan analysis in
Scientists use advanced imaging to map uncharted area of genome
Using advanced imaging techniques, researchers at the University of Colorado
Precision medicine: Advanced data analysis enhances prenatal genetic testing
Scientists have published a novel computational framework for highly accurate
FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
PRINCETON, N.J., February 25, 2019 – Taiho Oncology, Inc. today
Drug combination may become new standard treatment for advanced kidney cancer
A combination of two drugs—one of them an immunotherapy agent—could
Immunotherapy keeps some advanced head and neck cancer patients alive for over three years
A new immunotherapy can greatly extend the lives of a
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a